Prednisone is NOT recommended for severe acute back pain
For severe acute back pain, prednisone dose packs should not be used, as high-quality evidence demonstrates no benefit for pain relief or functional improvement. The 2017 systematic review for the American College of Physicians found that systemic corticosteroids consistently showed no differences from placebo in pain intensity or function for both acute nonradicular low back pain and radicular pain (sciatica) 1. This is further supported by the 2007 ACP/APS guideline, which does not recommend corticosteroids for low back pain management 2.
Evidence Against Prednisone Use
The evidence is clear and consistent:
Acute nonradicular back pain: Two trials found no differences between systemic corticosteroids (single intramuscular injection or 5-day course) and placebo in pain or function 1
Radicular back pain (sciatica): Six trials consistently found no differences between systemic corticosteroids and placebo in pain relief. While one large trial (n=269) showed small functional improvements (7.4-point difference on Oswestry Disability Index at 52 weeks), this was not clinically meaningful 1
Randomized controlled trial: A 2014 ED study of 79 patients with musculoskeletal low back pain found that 50 mg prednisone daily for 5 days provided no benefit compared to placebo. Notably, more patients in the prednisone group (40%) sought additional medical treatment compared to placebo (18%), suggesting potential harm 3
Harms of Prednisone
The largest trial documented significant adverse effects from oral prednisone (initial dose 60 mg/day) 1:
- Any adverse event: 49% vs. 24% (p<0.001)
- Insomnia: 26% vs. 10% (p=0.003)
- Nervousness: 18% vs. 8% (p=0.03)
- Increased appetite: 22% vs. 10% (p=0.02)
Recommended Treatment Instead
First-line therapy should be acetaminophen or NSAIDs 2:
- Acetaminophen is reasonable first-line due to favorable safety profile and low cost
- NSAIDs are more effective than acetaminophen (approximately 10 points better on 100-point pain scale) but require cardiovascular and gastrointestinal risk assessment
- Use lowest effective doses for shortest necessary duration
For severe, disabling pain not controlled by acetaminophen/NSAIDs: Consider judicious short-term opioid analgesics or tramadol, with careful risk-benefit assessment 2
Skeletal muscle relaxants may provide short-term relief for acute back pain but cause sedation 2
Important Caveat: Cervical Radiculopathy
One exception exists: A 2013 trial found that prednisone 50 mg/day for 5 days (tapered over following 5 days) was highly effective for cervical radiculopathy specifically, with 75.8% improvement vs. 30% with placebo 4. However, this does not apply to lumbar back pain, which is what most patients mean by "severe back pain."
Clinical Bottom Line
Do not prescribe prednisone dose packs for severe acute back pain. The evidence shows no benefit, significant adverse effects, and potentially increased healthcare utilization. Start with NSAIDs (if no contraindications) or acetaminophen, provide reassurance about natural history, and encourage activity as tolerated.